CLIMB BIO INC. - COMMON STOCK
3,0500
22-ноября-24 16:44:58
15 мин. задержка
Акции
+0,0500
+1,67%
Сегодняшний диапазон
3,0150 - 3,3000
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
08 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Update on Pipeline Progress
05 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Second Quarter Financial and Business Highlights
15 авг 2022 06:10:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides ETX-810 Program Update
02 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
18 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022
07 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
27 июн 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports First Quarter Financial and Business Highlights
16 май 2022 06:10:00 Источник Nasdaq GlobeNewswire
-
Eliem Provides Update on ETX-810 and ETX-155 Clinical Programs
25 апр 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs
05 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics to Present at Stifel’s 2022 CNS Days
21 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights
07 мар 2022 16:10:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
11 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
07 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Program Updates and an Overview of Expected Near-Term Milestones
18 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
08 ноя 2021 16:01:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics to Participate at Four Upcoming Investor Conferences
04 ноя 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Second Quarter Financial Results
13 сен 2021 16:10:00 Источник Nasdaq GlobeNewswire
-
12 авг 2021 21:06:11 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Pricing of Initial Public Offering
09 авг 2021 22:33:09 Источник Nasdaq GlobeNewswire